Biologics Market Size, Share & Trends Report

Biologics Market Size, Share & Trends Analysis Report By Source (Microbial, Mammalian), By Product (MABs, Recombinant Proteins, Antisense & RNAi), By Disease Category, By Manufacturing, By Region, And Segment Forecasts, 2023 - 2030

  • Report ID: GVR-1-68038-700-1
  • Number of Pages: 120
  • Format: Electronic (PDF)
  • Historical Range: 2018 - 2021
  • Industry: Healthcare

Market Segmentation

  • Biologics Source Outlook (Revenue, USD Billion, 2018 - 2030)
    • Microbial
    • Mammalian
    • Others
  • Biologics Product Outlook (Revenue, USD Billion, 2018 - 2030)
    • Monoclonal Antibodies 
      • MABs by Application
        • Diagnostic
          • Biochemical Analysis
          • Diagnostic Imaging
        • Therapeutic
          • Direct MAB Agents
          • Targeting MAB Agents
        • Protein Purification
        • Others
      • MABs by Type
        • Murine
        • Chimeric
        • Humanized
        • Human
        • Others
    • Vaccines
    • Recombinant Proteins
    • Antisense & RNAi Therapeutics
    • Others
  • Biologics Disease Category Outlook (Revenue, USD Billion, 2018 - 2030)
    • Oncology
      • By Product
        • MABs
        • Vaccines
        • Recombinant Proteins
        • Antisense & RNAi Therapeutics
        • Others (Certain products under trials related to blood products etc)
    • Infectious Diseases
      • By Product
        • Vaccines
        • MABs
        • Antisense & RNAi Therapeutics
        • Recombinant Proteins
        • Others
    • Immunological Disorders
    • Cardiovascular Disorders
    • Hematological Disorders
    • Others
  • Biologics Manufacturing Outlook (Revenue, USD Billion, 2018 - 2030)
    • Outsourced
    • In-house
  • Biologics Regional Outlook (Revenue, USD Billion, 2018 - 2030)
    • North America
      • North America Biologics Market, By Source
        • Microbial
        • Mammalian
        • Others
      • North America Biologics Market, By Product
        • Monoclonal Antibodies 
          • MABs by Application
            • Diagnostic
              • Biochemical Analysis
              • Diagnostic Imaging
            • Therapeutic
              • Direct MAB Agents
              • Targeting MAB Agents
            • Protein Purification
            • Others
          • MABs by Type
            • Murine
            • Chimeric
            • Humanized
            • Human
            • Others
        • Vaccines
        • Recombinant Proteins
        • Antisense & RNAi Therapeutics
        • Others
      • North America Biologics Market, By Manufacturing
        • Oncology
          • By Product
            • MABs
            • Vaccines
            • Recombinant Proteins
            • Antisense & RNAi Therapeutics
            • Others (Certain products under trials related to blood products etc)
        • Infectious Diseases
          • By Product
            • Vaccines
            • MABs
            • Antisense & RNAi Therapeutics
            • Recombinant Proteins
            • Others
        • Immunological Disorders
        • Cardiovascular Disorders
        • Hematological Disorders
        • Others
      • North America Biologics Market, By Disease Category
        • Outsourced
        • In-house
      • U.S.
        • U.S. Biologics Market, By Source
          • Microbial
          • Mammalian
          • Others
        • U.S. Biologics Market, By Product
          • Monoclonal Antibodies 
            • MABs by Application
              • Diagnostic
                • Biochemical Analysis
                • Diagnostic Imaging
              • Therapeutic
                • Direct MAB Agents
                • Targeting MAB Agents
              • Protein Purification
              • Others
            • MABs by Type
              • Murine
              • Chimeric
              • Humanized
              • Human
              • Others
          • Vaccines
          • Recombinant Proteins
          • Antisense & RNAi Therapeutics
          • Others
        • U.S. Biologics Market, By Manufacturing
          • Oncology
            • By Product
              • MABs
              • Vaccines
              • Recombinant Proteins
              • Antisense & RNAi Therapeutics
              • Others (Certain products under trials related to blood products etc)
          • Infectious Diseases
            • By Product
              • Vaccines
              • MABs
              • Antisense & RNAi Therapeutics
              • Recombinant Proteins
              • Others
          • Immunological Disorders
          • Cardiovascular Disorders
          • Hematological Disorders
          • Others
        • U.S. Biologics Market, By Disease Category
          • Outsourced
          • In-house
      • Canada
        • Canada Biologics Market, By Source
          • Microbial
          • Mammalian
          • Others
        • Canada Biologics Market, By Product
          • Monoclonal Antibodies 
            • MABs by Application
              • Diagnostic
                • Biochemical Analysis
                • Diagnostic Imaging
              • Therapeutic
                • Direct MAB Agents
                • Targeting MAB Agents
              • Protein Purification
              • Others
            • MABs by Type
              • Murine
              • Chimeric
              • Humanized
              • Human
              • Others
          • Vaccines
          • Recombinant Proteins
          • Antisense & RNAi Therapeutics
          • Others
        • Canada Biologics Market, By Manufacturing
          • Oncology
            • By Product
              • MABs
              • Vaccines
              • Recombinant Proteins
              • Antisense & RNAi Therapeutics
              • Others (Certain products under trials related to blood products etc)
          • Infectious Diseases
            • By Product
              • Vaccines
              • MABs
              • Antisense & RNAi Therapeutics
              • Recombinant Proteins
              • Others
          • Immunological Disorders
          • Cardiovascular Disorders
          • Hematological Disorders
          • Others
        • Canada Biologics Market, By Disease Category
          • Outsourced
          • In-house
    • Europe
      • Europe Biologics Market, By Source
        • Microbial
        • Mammalian
        • Others
      • Europe Biologics Market, By Product
        • Monoclonal Antibodies 
          • MABs by Application
            • Diagnostic
              • Biochemical Analysis
              • Diagnostic Imaging
            • Therapeutic
              • Direct MAB Agents
              • Targeting MAB Agents
            • Protein Purification
            • Others
          • MABs by Type
            • Murine
            • Chimeric
            • Humanized
            • Human
            • Others
        • Vaccines
        • Recombinant Proteins
        • Antisense & RNAi Therapeutics
        • Others
      • Europe Biologics Market, By Manufacturing
        • Oncology
          • By Product
            • MABs
            • Vaccines
            • Recombinant Proteins
            • Antisense & RNAi Therapeutics
            • Others (Certain products under trials related to blood products etc)
        • Infectious Diseases
          • By Product
            • Vaccines
            • MABs
            • Antisense & RNAi Therapeutics
            • Recombinant Proteins
            • Others
        • Immunological Disorders
        • Cardiovascular Disorders
        • Hematological Disorders
        • Others
      • Europe Biologics Market, By Disease Category
        • Outsourced
        • In-house
      • Germany
        • Germany Biologics Market, By Source
          • Microbial
          • Mammalian
          • Others
        • Germany Biologics Market, By Product
          • Monoclonal Antibodies 
            • MABs by Application
              • Diagnostic
                • Biochemical Analysis
                • Diagnostic Imaging
              • Therapeutic
                • Direct MAB Agents
                • Targeting MAB Agents
              • Protein Purification
              • Others
            • MABs by Type
              • Murine
              • Chimeric
              • Humanized
              • Human
              • Others
          • Vaccines
          • Recombinant Proteins
          • Antisense & RNAi Therapeutics
          • Others
        • Germany Biologics Market, By Manufacturing
          • Oncology
            • By Product
              • MABs
              • Vaccines
              • Recombinant Proteins
              • Antisense & RNAi Therapeutics
              • Others (Certain products under trials related to blood products etc)
          • Infectious Diseases
            • By Product
              • Vaccines
              • MABs
              • Antisense & RNAi Therapeutics
              • Recombinant Proteins
              • Others
          • Immunological Disorders
          • Cardiovascular Disorders
          • Hematological Disorders
          • Others
        • Germany Biologics Market, By Disease Category
          • Outsourced
          • In-house
      • U.K.
        • U.K. Biologics Market, By Source
          • Microbial
          • Mammalian
          • Others
        • U.K. Biologics Market, By Product
          • Monoclonal Antibodies 
            • MABs by Application
              • Diagnostic
                • Biochemical Analysis
                • Diagnostic Imaging
              • Therapeutic
                • Direct MAB Agents
                • Targeting MAB Agents
              • Protein Purification
              • Others
            • MABs by Type
              • Murine
              • Chimeric
              • Humanized
              • Human
              • Others
          • Vaccines
          • Recombinant Proteins
          • Antisense & RNAi Therapeutics
          • Others
        • U.K. Biologics Market, By Manufacturing
          • Oncology
            • By Product
              • MABs
              • Vaccines
              • Recombinant Proteins
              • Antisense & RNAi Therapeutics
              • Others (Certain products under trials related to blood products etc)
          • Infectious Diseases
            • By Product
              • Vaccines
              • MABs
              • Antisense & RNAi Therapeutics
              • Recombinant Proteins
              • Others
          • Immunological Disorders
          • Cardiovascular Disorders
          • Hematological Disorders
          • Others
        • U.K. Biologics Market, By Disease Category
          • Outsourced
          • In-house
      • France
        • France Biologics Market, By Source
          • Microbial
          • Mammalian
          • Others
        • France Biologics Market, By Product
          • Monoclonal Antibodies 
            • MABs by Application
              • Diagnostic
                • Biochemical Analysis
                • Diagnostic Imaging
              • Therapeutic
                • Direct MAB Agents
                • Targeting MAB Agents
              • Protein Purification
              • Others
            • MABs by Type
              • Murine
              • Chimeric
              • Humanized
              • Human
              • Others
          • Vaccines
          • Recombinant Proteins
          • Antisense & RNAi Therapeutics
          • Others
        • France Biologics Market, By Manufacturing
          • Oncology
            • By Product
              • MABs
              • Vaccines
              • Recombinant Proteins
              • Antisense & RNAi Therapeutics
              • Others (Certain products under trials related to blood products etc)
          • Infectious Diseases
            • By Product
              • Vaccines
              • MABs
              • Antisense & RNAi Therapeutics
              • Recombinant Proteins
              • Others
          • Immunological Disorders
          • Cardiovascular Disorders
          • Hematological Disorders
          • Others
        • France Biologics Market, By Disease Category
          • Outsourced
          • In-house
      • Italy
        • Italy Biologics Market, By Source
          • Microbial
          • Mammalian
          • Others
        • Italy Biologics Market, By Product
          • Monoclonal Antibodies 
            • MABs by Application
              • Diagnostic
                • Biochemical Analysis
                • Diagnostic Imaging
              • Therapeutic
                • Direct MAB Agents
                • Targeting MAB Agents
              • Protein Purification
              • Others
            • MABs by Type
              • Murine
              • Chimeric
              • Humanized
              • Human
              • Others
          • Vaccines
          • Recombinant Proteins
          • Antisense & RNAi Therapeutics
          • Others
        • Italy Biologics Market, By Manufacturing
          • Oncology
            • By Product
              • MABs
              • Vaccines
              • Recombinant Proteins
              • Antisense & RNAi Therapeutics
              • Others (Certain products under trials related to blood products etc)
          • Infectious Diseases
            • By Product
              • Vaccines
              • MABs
              • Antisense & RNAi Therapeutics
              • Recombinant Proteins
              • Others
          • Immunological Disorders
          • Cardiovascular Disorders
          • Hematological Disorders
          • Others
        • Italy Biologics Market, By Disease Category
          • Outsourced
          • In-house
      • Spain
        • Spain Biologics Market, By Source
          • Microbial
          • Mammalian
          • Others
        • Spain Biologics Market, By Product
          • Monoclonal Antibodies 
            • MABs by Application
              • Diagnostic
                • Biochemical Analysis
                • Diagnostic Imaging
              • Therapeutic
                • Direct MAB Agents
                • Targeting MAB Agents
              • Protein Purification
              • Others
            • MABs by Type
              • Murine
              • Chimeric
              • Humanized
              • Human
              • Others
          • Vaccines
          • Recombinant Proteins
          • Antisense & RNAi Therapeutics
          • Others
        • Spain Biologics Market, By Manufacturing
          • Oncology
            • By Product
              • MABs
              • Vaccines
              • Recombinant Proteins
              • Antisense & RNAi Therapeutics
              • Others (Certain products under trials related to blood products etc)
          • Infectious Diseases
            • By Product
              • Vaccines
              • MABs
              • Antisense & RNAi Therapeutics
              • Recombinant Proteins
              • Others
          • Immunological Disorders
          • Cardiovascular Disorders
          • Hematological Disorders
          • Others
        • Spain Biologics Market, By Disease Category
          • Outsourced
          • In-house
      • Denmark
        • Denmark Biologics Market, By Source
          • Microbial
          • Mammalian
          • Others
        • Denmark Biologics Market, By Product
          • Monoclonal Antibodies 
            • MABs by Application
              • Diagnostic
                • Biochemical Analysis
                • Diagnostic Imaging
              • Therapeutic
                • Direct MAB Agents
                • Targeting MAB Agents
              • Protein Purification
              • Others
            • MABs by Type
              • Murine
              • Chimeric
              • Humanized
              • Human
              • Others
          • Vaccines
          • Recombinant Proteins
          • Antisense & RNAi Therapeutics
          • Others
        • Denmark Biologics Market, By Manufacturing
          • Oncology
            • By Product
              • MABs
              • Vaccines
              • Recombinant Proteins
              • Antisense & RNAi Therapeutics
              • Others (Certain products under trials related to blood products etc)
          • Infectious Diseases
            • By Product
              • Vaccines
              • MABs
              • Antisense & RNAi Therapeutics
              • Recombinant Proteins
              • Others
          • Immunological Disorders
          • Cardiovascular Disorders
          • Hematological Disorders
          • Others
        • Denmark Biologics Market, By Disease Category
          • Outsourced
          • In-house
      • Sweden
        • Sweden Biologics Market, By Source
          • Microbial
          • Mammalian
          • Others
        • Sweden Biologics Market, By Product
          • Monoclonal Antibodies 
            • MABs by Application
              • Diagnostic
                • Biochemical Analysis
                • Diagnostic Imaging
              • Therapeutic
                • Direct MAB Agents
                • Targeting MAB Agents
              • Protein Purification
              • Others
            • MABs by Type
              • Murine
              • Chimeric
              • Humanized
              • Human
              • Others
          • Vaccines
          • Recombinant Proteins
          • Antisense & RNAi Therapeutics
          • Others
        • Sweden Biologics Market, By Manufacturing
          • Oncology
            • By Product
              • MABs
              • Vaccines
              • Recombinant Proteins
              • Antisense & RNAi Therapeutics
              • Others (Certain products under trials related to blood products etc)
          • Infectious Diseases
            • By Product
              • Vaccines
              • MABs
              • Antisense & RNAi Therapeutics
              • Recombinant Proteins
              • Others
          • Immunological Disorders
          • Cardiovascular Disorders
          • Hematological Disorders
          • Others
        • Sweden Biologics Market, By Disease Category
          • Outsourced
          • In-house
      • Norway
        • Norway Biologics Market, By Source
          • Microbial
          • Mammalian
          • Others
        • Norway Biologics Market, By Product
          • Monoclonal Antibodies 
            • MABs by Application
              • Diagnostic
                • Biochemical Analysis
                • Diagnostic Imaging
              • Therapeutic
                • Direct MAB Agents
                • Targeting MAB Agents
              • Protein Purification
              • Others
            • MABs by Type
              • Murine
              • Chimeric
              • Humanized
              • Human
              • Others
          • Vaccines
          • Recombinant Proteins
          • Antisense & RNAi Therapeutics
          • Others
        • Norway Biologics Market, By Manufacturing
          • Oncology
            • By Product
              • MABs
              • Vaccines
              • Recombinant Proteins
              • Antisense & RNAi Therapeutics
              • Others (Certain products under trials related to blood products etc)
          • Infectious Diseases
            • By Product
              • Vaccines
              • MABs
              • Antisense & RNAi Therapeutics
              • Recombinant Proteins
              • Others
          • Immunological Disorders
          • Cardiovascular Disorders
          • Hematological Disorders
          • Others
        • Norway Biologics Market, By Disease Category
          • Outsourced
          • In-house
    • Asia Pacific
      • Asia Pacific Biologics Market, By Source
        • Microbial
        • Mammalian
        • Others
      • Asia Pacific Biologics Market, By Product
        • Monoclonal Antibodies 
          • MABs by Application
            • Diagnostic
              • Biochemical Analysis
              • Diagnostic Imaging
            • Therapeutic
              • Direct MAB Agents
              • Targeting MAB Agents
            • Protein Purification
            • Others
          • MABs by Type
            • Murine
            • Chimeric
            • Humanized
            • Human
            • Others
        • Vaccines
        • Recombinant Proteins
        • Antisense & RNAi Therapeutics
        • Others
      • Asia Pacific Biologics Market, By Manufacturing
        • Oncology
          • By Product
            • MABs
            • Vaccines
            • Recombinant Proteins
            • Antisense & RNAi Therapeutics
            • Others (Certain products under trials related to blood products etc)
        • Infectious Diseases
          • By Product
            • Vaccines
            • MABs
            • Antisense & RNAi Therapeutics
            • Recombinant Proteins
            • Others
        • Immunological Disorders
        • Cardiovascular Disorders
        • Hematological Disorders
        • Others
      • Asia Pacific Biologics Market, By Disease Category
        • Outsourced
        • In-house
      • Japan
        • Japan Biologics Market, By Source
          • Microbial
          • Mammalian
          • Others
        • Japan Biologics Market, By Product
          • Monoclonal Antibodies 
            • MABs by Application
              • Diagnostic
                • Biochemical Analysis
                • Diagnostic Imaging
              • Therapeutic
                • Direct MAB Agents
                • Targeting MAB Agents
              • Protein Purification
              • Others
            • MABs by Type
              • Murine
              • Chimeric
              • Humanized
              • Human
              • Others
          • Vaccines
          • Recombinant Proteins
          • Antisense & RNAi Therapeutics
          • Others
        • Japan Biologics Market, By Manufacturing
          • Oncology
            • By Product
              • MABs
              • Vaccines
              • Recombinant Proteins
              • Antisense & RNAi Therapeutics
              • Others (Certain products under trials related to blood products etc)
          • Infectious Diseases
            • By Product
              • Vaccines
              • MABs
              • Antisense & RNAi Therapeutics
              • Recombinant Proteins
              • Others
          • Immunological Disorders
          • Cardiovascular Disorders
          • Hematological Disorders
          • Others
        • Japan Biologics Market, By Disease Category
          • Outsourced
          • In-house
      • China
        • China Biologics Market, By Source
          • Microbial
          • Mammalian
          • Others
        • China Biologics Market, By Product
          • Monoclonal Antibodies 
            • MABs by Application
              • Diagnostic
                • Biochemical Analysis
                • Diagnostic Imaging
              • Therapeutic
                • Direct MAB Agents
                • Targeting MAB Agents
              • Protein Purification
              • Others
            • MABs by Type
              • Murine
              • Chimeric
              • Humanized
              • Human
              • Others
          • Vaccines
          • Recombinant Proteins
          • Antisense & RNAi Therapeutics
          • Others
        • China Biologics Market, By Manufacturing
          • Oncology
            • By Product
              • MABs
              • Vaccines
              • Recombinant Proteins
              • Antisense & RNAi Therapeutics
              • Others (Certain products under trials related to blood products etc)
          • Infectious Diseases
            • By Product
              • Vaccines
              • MABs
              • Antisense & RNAi Therapeutics
              • Recombinant Proteins
              • Others
          • Immunological Disorders
          • Cardiovascular Disorders
          • Hematological Disorders
          • Others
        • China  Biologics Market, By Disease Category
          • Outsourced
          • In-house
      • India
        • India Biologics Market, By Source
          • Microbial
          • Mammalian
          • Others
        • India Biologics Market, By Product
          • Monoclonal Antibodies 
            • MABs by Application
              • Diagnostic
                • Biochemical Analysis
                • Diagnostic Imaging
              • Therapeutic
                • Direct MAB Agents
                • Targeting MAB Agents
              • Protein Purification
              • Others
            • MABs by Type
              • Murine
              • Chimeric
              • Humanized
              • Human
              • Others
          • Vaccines
          • Recombinant Proteins
          • Antisense & RNAi Therapeutics
          • Others
        • India Biologics Market, By Manufacturing
          • Oncology
            • By Product
              • MABs
              • Vaccines
              • Recombinant Proteins
              • Antisense & RNAi Therapeutics
              • Others (Certain products under trials related to blood products etc)
          • Infectious Diseases
            • By Product
              • Vaccines
              • MABs
              • Antisense & RNAi Therapeutics
              • Recombinant Proteins
              • Others
          • Immunological Disorders
          • Cardiovascular Disorders
          • Hematological Disorders
          • Others
        • India Biologics Market, By Disease Category
          • Outsourced
          • In-house
      • Australia
        • Australia Biologics Market, By Source
          • Microbial
          • Mammalian
          • Others
        • Australia Biologics Market, By Product
          • Monoclonal Antibodies 
            • MABs by Application
              • Diagnostic
                • Biochemical Analysis
                • Diagnostic Imaging
              • Therapeutic
                • Direct MAB Agents
                • Targeting MAB Agents
              • Protein Purification
              • Others
            • MABs by Type
              • Murine
              • Chimeric
              • Humanized
              • Human
              • Others
          • Vaccines
          • Recombinant Proteins
          • Antisense & RNAi Therapeutics
          • Others
        • Australia Biologics Market, By Manufacturing
          • Oncology
            • By Product
              • MABs
              • Vaccines
              • Recombinant Proteins
              • Antisense & RNAi Therapeutics
              • Others (Certain products under trials related to blood products etc)
          • Infectious Diseases
            • By Product
              • Vaccines
              • MABs
              • Antisense & RNAi Therapeutics
              • Recombinant Proteins
              • Others
          • Immunological Disorders
          • Cardiovascular Disorders
          • Hematological Disorders
          • Others
        • Australia Biologics Market, By Disease Category
          • Outsourced
          • In-house
      • South Korea
        • South Korea Biologics Market, By Source
          • Microbial
          • Mammalian
          • Others
        • v Biologics Market, By Product
          • Monoclonal Antibodies 
            • MABs by Application
              • Diagnostic
                • Biochemical Analysis
                • Diagnostic Imaging
              • Therapeutic
                • Direct MAB Agents
                • Targeting MAB Agents
              • Protein Purification
              • Others
            • MABs by Type
              • Murine
              • Chimeric
              • Humanized
              • Human
              • Others
          • Vaccines
          • Recombinant Proteins
          • Antisense & RNAi Therapeutics
          • Others
        • South Korea Biologics Market, By Manufacturing
          • Oncology
            • By Product
              • MABs
              • Vaccines
              • Recombinant Proteins
              • Antisense & RNAi Therapeutics
              • Others (Certain products under trials related to blood products etc)
          • Infectious Diseases
            • By Product
              • Vaccines
              • MABs
              • Antisense & RNAi Therapeutics
              • Recombinant Proteins
              • Others
          • Immunological Disorders
          • Cardiovascular Disorders
          • Hematological Disorders
          • Others
        • South Korea Biologics Market, By Disease Category
          • Outsourced
          • In-house
      • Thailand
        • Thailand  Biologics Market, By Source
          • Microbial
          • Mammalian
          • Others
        • Thailand Biologics Market, By Product
          • Monoclonal Antibodies 
            • MABs by Application
              • Diagnostic
                • Biochemical Analysis
                • Diagnostic Imaging
              • Therapeutic
                • Direct MAB Agents
                • Targeting MAB Agents
              • Protein Purification
              • Others
            • MABs by Type
              • Murine
              • Chimeric
              • Humanized
              • Human
              • Others
          • Vaccines
          • Recombinant Proteins
          • Antisense & RNAi Therapeutics
          • Others
        • Thailand Biologics Market, By Manufacturing
          • Oncology
            • By Product
              • MABs
              • Vaccines
              • Recombinant Proteins
              • Antisense & RNAi Therapeutics
              • Others (Certain products under trials related to blood products etc)
          • Infectious Diseases
            • By Product
              • Vaccines
              • MABs
              • Antisense & RNAi Therapeutics
              • Recombinant Proteins
              • Others
          • Immunological Disorders
          • Cardiovascular Disorders
          • Hematological Disorders
          • Others
        • Thailand Biologics Market, By Disease Category
          • Outsourced
          • In-house
    • Latin America
      • Latin America Biologics Market, By Source
        • Microbial
        • Mammalian
        • Others
      • Latin America Biologics Market, By Product
        • Monoclonal Antibodies 
          • MABs by Application
            • Diagnostic
              • Biochemical Analysis
              • Diagnostic Imaging
            • Therapeutic
              • Direct MAB Agents
              • Targeting MAB Agents
            • Protein Purification
            • Others
          • MABs by Type
            • Murine
            • Chimeric
            • Humanized
            • Human
            • Others
        • Vaccines
        • Recombinant Proteins
        • Antisense & RNAi Therapeutics
        • Others
      • Latin America Biologics Market, By Manufacturing
        • Oncology
          • By Product
            • MABs
            • Vaccines
            • Recombinant Proteins
            • Antisense & RNAi Therapeutics
            • Others (Certain products under trials related to blood products etc)
        • Infectious Diseases
          • By Product
            • Vaccines
            • MABs
            • Antisense & RNAi Therapeutics
            • Recombinant Proteins
            • Others
        • Immunological Disorders
        • Cardiovascular Disorders
        • Hematological Disorders
        • Others
      • Latin America Biologics Market, By Disease Category
        • Outsourced
        • In-house
      • Brazil
        • Brazil Biologics Market, By Source
          • Microbial
          • Mammalian
          • Others
        • Brazil Biologics Market, By Product
          • Monoclonal Antibodies 
            • MABs by Application
              • Diagnostic
                • Biochemical Analysis
                • Diagnostic Imaging
              • Therapeutic
                • Direct MAB Agents
                • Targeting MAB Agents
              • Protein Purification
              • Others
            • MABs by Type
              • Murine
              • Chimeric
              • Humanized
              • Human
              • Others
          • Vaccines
          • Recombinant Proteins
          • Antisense & RNAi Therapeutics
          • Others
        • Brazil Biologics Market, By Manufacturing
          • Oncology
            • By Product
              • MABs
              • Vaccines
              • Recombinant Proteins
              • Antisense & RNAi Therapeutics
              • Others (Certain products under trials related to blood products etc)
          • Infectious Diseases
            • By Product
              • Vaccines
              • MABs
              • Antisense & RNAi Therapeutics
              • Recombinant Proteins
              • Others
          • Immunological Disorders
          • Cardiovascular Disorders
          • Hematological Disorders
          • Others
        • Brazil Biologics Market, By Disease Category
          • Outsourced
          • In-house
      • Mexico
        • Mexico Biologics Market, By Source
          • Microbial
          • Mammalian
          • Others
        • Mexico Biologics Market, By Product
          • Monoclonal Antibodies 
            • MABs by Application
              • Diagnostic
                • Biochemical Analysis
                • Diagnostic Imaging
              • Therapeutic
                • Direct MAB Agents
                • Targeting MAB Agents
              • Protein Purification
              • Others
            • MABs by Type
              • Murine
              • Chimeric
              • Humanized
              • Human
              • Others
          • Vaccines
          • Recombinant Proteins
          • Antisense & RNAi Therapeutics
          • Others
        • Mexico Biologics Market, By Manufacturing
          • Oncology
            • By Product
              • MABs
              • Vaccines
              • Recombinant Proteins
              • Antisense & RNAi Therapeutics
              • Others (Certain products under trials related to blood products etc)
          • Infectious Diseases
            • By Product
              • Vaccines
              • MABs
              • Antisense & RNAi Therapeutics
              • Recombinant Proteins
              • Others
          • Immunological Disorders
          • Cardiovascular Disorders
          • Hematological Disorders
          • Others
        • Mexico  Biologics Market, By Disease Category
          • Outsourced
          • In-house
      • Argentina
        • Argentina Biologics Market, By Source
          • Microbial
          • Mammalian
          • Others
        • Argentina  Biologics Market, By Product
          • Monoclonal Antibodies 
            • MABs by Application
              • Diagnostic
                • Biochemical Analysis
                • Diagnostic Imaging
              • Therapeutic
                • Direct MAB Agents
                • Targeting MAB Agents
              • Protein Purification
              • Others
            • MABs by Type
              • Murine
              • Chimeric
              • Humanized
              • Human
              • Others
          • Vaccines
          • Recombinant Proteins
          • Antisense & RNAi Therapeutics
          • Others
        • Argentina Biologics Market, By Manufacturing
          • Oncology
            • By Product
              • MABs
              • Vaccines
              • Recombinant Proteins
              • Antisense & RNAi Therapeutics
              • Others (Certain products under trials related to blood products etc)
          • Infectious Diseases
            • By Product
              • Vaccines
              • MABs
              • Antisense & RNAi Therapeutics
              • Recombinant Proteins
              • Others
          • Immunological Disorders
          • Cardiovascular Disorders
          • Hematological Disorders
          • Others
        • Argentina Biologics Market, By Disease Category
          • Outsourced
          • In-house
    • Middle East and Africa (MEA)
      • MEA Biologics Market, By Source
        • Microbial
        • Mammalian
        • Others
      • MEA Biologics Market, By Product
        • Monoclonal Antibodies 
          • MABs by Application
            • Diagnostic
              • Biochemical Analysis
              • Diagnostic Imaging
            • Therapeutic
              • Direct MAB Agents
              • Targeting MAB Agents
            • Protein Purification
            • Others
          • MABs by Type
            • Murine
            • Chimeric
            • Humanized
            • Human
            • Others
        • Vaccines
        • Recombinant Proteins
        • Antisense & RNAi Therapeutics
        • Others
      • MEA Biologics Market, By Manufacturing
        • Oncology
          • By Product
            • MABs
            • Vaccines
            • Recombinant Proteins
            • Antisense & RNAi Therapeutics
            • Others (Certain products under trials related to blood products etc)
        • Infectious Diseases
          • By Product
            • Vaccines
            • MABs
            • Antisense & RNAi Therapeutics
            • Recombinant Proteins
            • Others
        • Immunological Disorders
        • Cardiovascular Disorders
        • Hematological Disorders
        • Others
      • MEA Biologics Market, By Disease Category
        • Outsourced
        • In-house
      • South Africa
        • South Africa Biologics Market, By Source
          • Microbial
          • Mammalian
          • Others
        • South Africa Biologics Market, By Product
          • Monoclonal Antibodies 
            • MABs by Application
              • Diagnostic
                • Biochemical Analysis
                • Diagnostic Imaging
              • Therapeutic
                • Direct MAB Agents
                • Targeting MAB Agents
              • Protein Purification
              • Others
            • MABs by Type
              • Murine
              • Chimeric
              • Humanized
              • Human
              • Others
          • Vaccines
          • Recombinant Proteins
          • Antisense & RNAi Therapeutics
          • Others
        • South Africa Biologics Market, By Manufacturing
          • Oncology
            • By Product
              • MABs
              • Vaccines
              • Recombinant Proteins
              • Antisense & RNAi Therapeutics
              • Others (Certain products under trials related to blood products etc)
          • Infectious Diseases
            • By Product
              • Vaccines
              • MABs
              • Antisense & RNAi Therapeutics
              • Recombinant Proteins
              • Others
          • Immunological Disorders
          • Cardiovascular Disorders
          • Hematological Disorders
          • Others
        • South Africa Biologics Market, By Disease Category
          • Outsourced
          • In-house
      • Saudi Arabia
        • Saudi Arabia Biologics Market, By Source
          • Microbial
          • Mammalian
          • Others
        • Saudi Arabia Biologics Market, By Product
          • Monoclonal Antibodies 
            • MABs by Application
              • Diagnostic
                • Biochemical Analysis
                • Diagnostic Imaging
              • Therapeutic
                • Direct MAB Agents
                • Targeting MAB Agents
              • Protein Purification
              • Others
            • MABs by Type
              • Murine
              • Chimeric
              • Humanized
              • Human
              • Others
          • Vaccines
          • Recombinant Proteins
          • Antisense & RNAi Therapeutics
          • Others
        • Saudi Arabia Biologics Market, By Manufacturing
          • Oncology
            • By Product
              • MABs
              • Vaccines
              • Recombinant Proteins
              • Antisense & RNAi Therapeutics
              • Others (Certain products under trials related to blood products etc)
          • Infectious Diseases
            • By Product
              • Vaccines
              • MABs
              • Antisense & RNAi Therapeutics
              • Recombinant Proteins
              • Others
          • Immunological Disorders
          • Cardiovascular Disorders
          • Hematological Disorders
          • Others
        • Saudi Arabia  Biologics Market, By Disease Category
          • Outsourced
          • In-house
      • UAE
        • UAE Biologics Market, By Source
          • Microbial
          • Mammalian
          • Others
        • UAE Biologics Market, By Product
          • Monoclonal Antibodies 
            • MABs by Application
              • Diagnostic
                • Biochemical Analysis
                • Diagnostic Imaging
              • Therapeutic
                • Direct MAB Agents
                • Targeting MAB Agents
              • Protein Purification
              • Others
            • MABs by Type
              • Murine
              • Chimeric
              • Humanized
              • Human
              • Others
          • Vaccines
          • Recombinant Proteins
          • Antisense & RNAi Therapeutics
          • Others
        • UAE Biologics Market, By Manufacturing
          • Oncology
            • By Product
              • MABs
              • Vaccines
              • Recombinant Proteins
              • Antisense & RNAi Therapeutics
              • Others (Certain products under trials related to blood products etc)
          • Infectious Diseases
            • By Product
              • Vaccines
              • MABs
              • Antisense & RNAi Therapeutics
              • Recombinant Proteins
              • Others
          • Immunological Disorders
          • Cardiovascular Disorders
          • Hematological Disorders
          • Others
        • UAE Biologics Market, By Disease Category
          • Outsourced
          • In-house
      • Kuwait
        • Kuwait Biologics Market, By Source
          • Microbial
          • Mammalian
          • Others
        • Kuwait Biologics Market, By Product
          • Monoclonal Antibodies 
            • MABs by Application
              • Diagnostic
                • Biochemical Analysis
                • Diagnostic Imaging
              • Therapeutic
                • Direct MAB Agents
                • Targeting MAB Agents
              • Protein Purification
              • Others
            • MABs by Type
              • Murine
              • Chimeric
              • Humanized
              • Human
              • Others
          • Vaccines
          • Recombinant Proteins
          • Antisense & RNAi Therapeutics
          • Others
        • Kuwait Biologics Market, By Manufacturing
          • Oncology
            • By Product
              • MABs
              • Vaccines
              • Recombinant Proteins
              • Antisense & RNAi Therapeutics
              • Others (Certain products under trials related to blood products etc)
          • Infectious Diseases
            • By Product
              • Vaccines
              • MABs
              • Antisense & RNAi Therapeutics
              • Recombinant Proteins
              • Others
          • Immunological Disorders
          • Cardiovascular Disorders
          • Hematological Disorders
          • Others
        • Kuwait Biologics Market, By Disease Category
          • Outsourced
          • In-house

Report content

Qualitative Analysis

  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porter’s analysis
  • PESTEL analysis
  • Key market opportunities prioritized
  • Competitive landscape
    • Company overview
    • Financial performance
    • Product benchmarking
    • Latest strategic developments

Quantitative Analysis

  • Market size, estimates, and forecast from 2018 to 2030
  • Market estimates and forecast for product segments up to 2030
  • Regional market size and forecast for product segments up to 2030
  • Market estimates and forecast for application segments up to 2030
  • Regional market size and forecast for application segments up to 2030
  • Company financial performance
What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

ISO

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon